A total of 80 patients were involved in the study — 40 people were screened before the first COVID-19 lockdown, and 40 people were screened after.
Researchers found the median circulating tumor DNA concentration among patients diagnosed after the lockdown was higher than those diagnosed before lockdown.
The study suggests that CRC is a major area for intervention to minimize pandemic-associated delays in screening, diagnosis and treatment.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
